---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-096322"
form_type: "8-K"
ticker: "ORMP"
cik: "0001176309"
company_name: "ORAMED PHARMACEUTICALS INC."
filed_at: "2025-10-06T23:59:59+00:00"
generated_at: "2026-05-17T04:32:58.691347+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Oramed receives $13M from Scilex in first tranche of warrant repurchase

## Summary
- Scilex repurchased warrants for 3,130,000 shares of Scilex common stock for $13,000,000 on Sept 30, 2025.
- Scilex retains option to repurchase remaining 3,370,000 warrants for $14,000,000 by Dec 31, 2025.
- Total aggregate purchase price for both tranches is $27,000,000; original option agreement was filed July 23, 2025.
- Warrants repurchased have an exercise price of $0.01 per share of Scilex common stock.

## SEC filing metadata
- accession: 0001213900-25-096322
- form_type: 8-K
- ticker: ORMP
- cik: 0001176309
- company_name: ORAMED PHARMACEUTICALS INC.
- filed_at: 2025-10-06T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1176309/000121390025096322/0001213900-25-096322-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1176309/000121390025096322/ea0260371-8k_oramed.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-096322
- JSON: https://secwatch.observer/filing/0001213900-25-096322.json
- Plain text: https://secwatch.observer/filing/0001213900-25-096322.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.